Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Validation of diagnosis codes to identify side of colon in an electronic health record registry.

Luhn P, Kuk D, Carrigan G, Nussbaum N, Sorg R, Rohrer R, Tucker MG, Arnieri B, Taylor MD, Meropol NJ.

BMC Med Res Methodol. 2019 Aug 19;19(1):177. doi: 10.1186/s12874-019-0824-7.

2.

Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab.

Postow MA, Chasalow SD, Kuk D, Panageas KS, Cheng ML, Yuan J, Wolchok JD.

Melanoma Res. 2019 Aug 14. doi: 10.1097/CMR.0000000000000633. [Epub ahead of print]

PMID:
31425479
3.

Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.

Khozin S, Miksad RA, Adami J, Boyd M, Brown NR, Gossai A, Kaganman I, Kuk D, Rockland JM, Pazdur R, Torres AZ, Zhi J, Abernethy AP.

Cancer. 2019 Aug 5. doi: 10.1002/cncr.32383. [Epub ahead of print]

PMID:
31381142
4.

Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis.

van Houdt WJ, Wei IH, Kuk D, Qin LX, Jadeja B, Villano A, Hameed M, Singer S, Crago AM.

Ann Surg Oncol. 2019 Mar;26(3):765-771. doi: 10.1245/s10434-018-07138-1. Epub 2019 Jan 4.

PMID:
30610557
5.

Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study.

Agarwala V, Khozin S, Singal G, O'Connell C, Kuk D, Li G, Gossai A, Miller V, Abernethy AP.

Health Aff (Millwood). 2018 May;37(5):765-772. doi: 10.1377/hlthaff.2017.1579. Review.

PMID:
29733723
6.

MeV electron acceleration at 1  kHz with <10  mJ laser pulses: erratum.

Salehi F, Goers AJ, Hine GA, Feder L, Kuk D, Miao B, Woodbury D, Kim KY, Milchberg HM.

Opt Lett. 2018 Apr 1;43(7):1610. doi: 10.1364/OL.43.001610.

PMID:
29601042
7.

Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors.

Gholami S, Cassidy MR, Kirane A, Kuk D, Zanchelli B, Antonescu CR, Singer S, Brennan M.

Ann Surg Oncol. 2017 Dec;24(13):3865-3871. doi: 10.1245/s10434-017-6092-z. Epub 2017 Oct 16.

PMID:
29039030
8.

Outcomes after inferior vena cava filter placement in cancer patients diagnosed with pulmonary embolism: risk for recurrent venous thromboembolism.

Coombs C, Kuk D, Devlin S, Siegelbaum RH, Durack JC, Parameswaran R, Mantha S, Deng K, Soff G.

J Thromb Thrombolysis. 2017 Nov;44(4):489-493. doi: 10.1007/s11239-017-1557-2.

PMID:
28993967
9.

Adenoma Prevalence in Blacks and Whites Having Equal Adherence To Screening Colonoscopy: The National Colonoscopy Study.

Mendelsohn RB, Winawer SJ, Jammula A, Mills G, Jordan P, O'Brien MJ, Close GM, Dorfman M, Church TR, Mandelson MT, Allen J, Feld A, Kauff ND, Morgan GA, Kumar JMR, Serrano V, Bayuga-Miller S, Fischer SE, Kuk D, Zauber AG.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1469-1470. doi: 10.1016/j.cgh.2017.04.014. Epub 2017 Apr 15. No abstract available.

10.

Measurement of the equation of state of solid-density copper heated with laser-accelerated protons.

Feldman S, Dyer G, Kuk D, Ditmire T.

Phys Rev E. 2017 Mar;95(3-1):031201. doi: 10.1103/PhysRevE.95.031201. Epub 2017 Mar 13.

PMID:
28415304
11.

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

Huang AC, Postow MA, Orlowski RJ, Mick R, Bengsch B, Manne S, Xu W, Harmon S, Giles JR, Wenz B, Adamow M, Kuk D, Panageas KS, Carrera C, Wong P, Quagliarello F, Wubbenhorst B, D'Andrea K, Pauken KE, Herati RS, Staupe RP, Schenkel JM, McGettigan S, Kothari S, George SM, Vonderheide RH, Amaravadi RK, Karakousis GC, Schuchter LM, Xu X, Nathanson KL, Wolchok JD, Gangadhar TC, Wherry EJ.

Nature. 2017 May 4;545(7652):60-65. doi: 10.1038/nature22079. Epub 2017 Apr 10.

12.

Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.

Cavnar MJ, Turcotte S, Katz SC, Kuk D, Gönen M, Shia J, Allen PJ, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, DeMatteo RP.

Ann Surg Oncol. 2017 Jul;24(7):1835-1842. doi: 10.1245/s10434-017-5812-8. Epub 2017 Feb 17.

13.

MeV electron acceleration at 1  kHz with <10  mJ laser pulses.

Salehi F, Goers AJ, Hine GA, Feder L, Kuk D, Miao B, Woodbury D, Kim KY, Milchberg HM.

Opt Lett. 2017 Jan 15;42(2):215-218. doi: 10.1364/OL.42.000215. Erratum in: Opt Lett. 2018 Apr 1;43(7):1610.

PMID:
28081077
14.

Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology-molecular associations: clinical and biological implications.

Shia J, Schultz N, Kuk D, Vakiani E, Middha S, Segal NH, Hechtman JF, Berger MF, Stadler ZK, Weiser MR, Wolchok JD, Boland CR, Gönen M, Klimstra DS.

Mod Pathol. 2017 Apr;30(4):599-609. doi: 10.1038/modpathol.2016.198. Epub 2016 Dec 16.

15.

MicroRNA-203 predicts human survival after resection of colorectal liver metastasis.

Kingham TP, Nguyen HCB, Zheng J, Konstantinidis IT, Sadot E, Shia J, Kuk D, Zhang S, Saltz L, D'Angelica MI, Jarnagin WR, Goodarzi H, Tavazoie SF.

Oncotarget. 2017 Mar 21;8(12):18821-18831. doi: 10.18632/oncotarget.13816.

16.

Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.

Zheng J, Kuk D, Gönen M, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, Jarnagin WR, DeMatteo RP.

Ann Surg Oncol. 2017 May;24(5):1358-1366. doi: 10.1245/s10434-016-5713-2. Epub 2016 Dec 5.

17.

The efficacy of anti-PD-1 agents in acral and mucosal melanoma.

Shoushtari AN, Munhoz RR, Kuk D, Ott PA, Johnson DB, Tsai KK, Rapisuwon S, Eroglu Z, Sullivan RJ, Luke JJ, Gangadhar TC, Salama AK, Clark V, Burias C, Puzanov I, Atkins MB, Algazi AP, Ribas A, Wolchok JD, Postow MA.

Cancer. 2016 Nov 15;122(21):3354-3362. doi: 10.1002/cncr.30259. Epub 2016 Aug 17.

18.

Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma.

Shoushtari AN, Landa J, Kuk D, Sanchez A, Lala B, Schmidt N, Okoli C, Chi P, Dickson MA, Gounder MM, Keohan ML, Crago AM, Tap WD, D'Angelo SP.

Sarcoma. 2016;2016:3547497. doi: 10.1155/2016/3547497. Epub 2016 May 29.

19.

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.

Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, Ariyan CE, Brady MS, Coit DG, Bogatch K, Callahan MK, Wolchok JD, Carvajal RD, Postow MA.

Oncologist. 2016 Jul;21(7):848-54. doi: 10.1634/theoncologist.2015-0522. Epub 2016 Jun 10.

20.

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.

Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide V, He J, Weiss MJ, Hruban RH, Gönen M, Klimstra DS, Mino-Kenudson M.

Ann Surg. 2017 Jan;265(1):185-191. doi: 10.1097/SLA.0000000000001763.

21.

Autologous transplant remains the preferred therapy for relapsed APL in CR2.

Ganzel C, Mathews V, Alimoghaddam K, Ghavamzadeh A, Kuk D, Devlin S, Wang H, Zhang MJ, Weisdorf D, Douer D, Rowe JM, Polge E, Esteve J, Nagler A, Mohty M, Tallman MS.

Bone Marrow Transplant. 2016 Sep;51(9):1180-3. doi: 10.1038/bmt.2016.96. Epub 2016 Apr 18.

22.

KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.

Chow OS, Kuk D, Keskin M, Smith JJ, Camacho N, Pelossof R, Chen CT, Chen Z, Avila K, Weiser MR, Berger MF, Patil S, Bergsland E, Garcia-Aguilar J.

Ann Surg Oncol. 2016 Aug;23(8):2548-55. doi: 10.1245/s10434-016-5205-4. Epub 2016 Mar 28.

23.

An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.

Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP.

Thyroid. 2016 Mar;26(3):373-80. doi: 10.1089/thy.2015.0315. Epub 2016 Feb 25.

24.

Robotic Liver Resection: A Case-Matched Comparison.

Kingham TP, Leung U, Kuk D, Gönen M, D'Angelica MI, Allen PJ, DeMatteo RP, Laudone VP, Jarnagin WR, Fong Y.

World J Surg. 2016 Jun;40(6):1422-8. doi: 10.1007/s00268-016-3446-9.

25.

Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.

Lee AY, Agaram NP, Qin LX, Kuk D, Curtin C, Brennan MF, Singer S.

Ann Surg Oncol. 2016 Mar;23(3):818-25. doi: 10.1245/s10434-015-5063-5. Epub 2016 Jan 12.

26.

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma.

Chhabra A, Ong LT, Kuk D, Ku G, Ilson D, Janjigian YY, Wu A, Schöder H, Goodman KA.

Br J Cancer. 2015 Dec 22;113(12):1658-65. doi: 10.1038/bjc.2015.416. Epub 2015 Dec 10.

27.

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.

Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Modak S, Kramer K, Roberts SS, Basu EM, Yataghene K, Cheung NK.

Oncotarget. 2016 Jan 26;7(4):4155-66. doi: 10.18632/oncotarget.6393.

28.

Targeted exome sequencing profiles genetic alterations in leiomyosarcoma.

Agaram NP, Zhang L, LeLoarer F, Silk T, Sung YS, Scott SN, Kuk D, Qin LX, Berger MF, Antonescu CR, Singer S.

Genes Chromosomes Cancer. 2016 Feb;55(2):124-30. doi: 10.1002/gcc.22318. Epub 2015 Nov 6.

29.

Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.

Gounder M, Desai V, Kuk D, Agaram N, Arcila M, Durham B, Keohan ML, Dickson MA, D'Angelo SP, Shukla N, Moskowitz C, Noy A, Maki RG, Herrera DA, Sanchez A, Krishnan A, Pourmoussa A, Qin LX, Tap WD.

Eur J Cancer. 2015 Nov;51(16):2413-22. doi: 10.1016/j.ejca.2015.06.109. Epub 2015 Aug 19.

30.

Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer.

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP.

Ann Surg Oncol. 2016 Feb;23(2):410-5. doi: 10.1245/s10434-015-4762-2. Epub 2015 Jul 28.

31.

Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.

Crago AM, Chmielecki J, Rosenberg M, O'Connor R, Byrne C, Wilder FG, Thorn K, Agius P, Kuk D, Socci ND, Qin LX, Meyerson M, Hameed M, Singer S.

Genes Chromosomes Cancer. 2015 Oct;54(10):606-15. doi: 10.1002/gcc.22272. Epub 2015 Jul 14.

32.

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study.

Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Kramer K, Modak S, Yataghene K, Cheung NK.

Oncoimmunology. 2015 May 22;4(7):e1016704. eCollection 2015 Jul.

33.

Comparison of Perioperative Radiation Therapy and Surgery Versus Surgery Alone in 204 Patients With Primary Retroperitoneal Sarcoma: A Retrospective 2-Institution Study.

Kelly KJ, Yoon SS, Kuk D, Qin LX, Dukleska K, Chang KK, Chen YL, Delaney TF, Brennan MF, Singer S.

Ann Surg. 2015 Jul;262(1):156-62. doi: 10.1097/SLA.0000000000001063.

34.

Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma.

D'Angelo SP, Munhoz RR, Kuk D, Landa J, Hartley EW, Bonafede M, Dickson MA, Gounder M, Keohan ML, Crago AM, Antonescu CR, Tap WD.

Oncology. 2015;89(4):205-14. doi: 10.1159/000381917. Epub 2015 Jun 3.

35.

[Percutaneous screw fixation of non- or minimally displaced scaphoid fractures].

Neshkova IS, Jakubietz RG, Kuk D, Jakubietz MG, Meffert RH, Schmidt K.

Oper Orthop Traumatol. 2015 Oct;27(5):448-54. doi: 10.1007/s00064-014-0325-0. Epub 2015 May 29. German.

PMID:
26018725
36.

Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.

Tan MC, Brennan MF, Kuk D, Agaram NP, Antonescu CR, Qin LX, Moraco N, Crago AM, Singer S.

Ann Surg. 2016 Mar;263(3):593-600. doi: 10.1097/SLA.0000000000001149.

37.

Response.

Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, Larson SM, Morris MJ, Scher HI, Hricak H.

Radiology. 2015 Feb;274(2):625. No abstract available.

PMID:
25785291
38.

Osteochondroma in long-term survivors of high-risk neuroblastoma.

Kushner BH, Roberts SS, Friedman DN, Kuk D, Ostrovnaya I, Modak S, Kramer K, Basu EM, Cheung NK.

Cancer. 2015 Jun 15;121(12):2090-6. doi: 10.1002/cncr.29316. Epub 2015 Feb 27.

39.

Soft tissue sarcoma of the head & neck: nomogram validation and analysis of staging systems.

Shuman AG, Brennan MF, Palmer FL, Kuk D, Moraco N, Singer S, Shah JP, Patel SG.

J Surg Oncol. 2015 May;111(6):690-5. doi: 10.1002/jso.23868. Epub 2015 Feb 24.

40.

Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.

Cheung NK, Ostrovnaya I, Kuk D, Cheung IY.

J Clin Oncol. 2015 Mar 1;33(7):755-63. doi: 10.1200/JCO.2014.57.6777. Epub 2015 Jan 5.

41.

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment.

D'Angelo SP, Shoushtari AN, Agaram NP, Kuk D, Qin LX, Carvajal RD, Dickson MA, Gounder M, Keohan ML, Schwartz GK, Tap WD.

Hum Pathol. 2015 Mar;46(3):357-65. doi: 10.1016/j.humpath.2014.11.001. Epub 2014 Nov 15.

42.

Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.

Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S, Cistaro A, Schöder H.

AJR Am J Roentgenol. 2015 Jan;204(1):153-60. doi: 10.2214/AJR.14.12932.

PMID:
25539251
43.

Ultrashort pulsed neutron source.

Pomerantz I, McCary E, Meadows AR, Arefiev A, Bernstein AC, Chester C, Cortez J, Donovan ME, Dyer G, Gaul EW, Hamilton D, Kuk D, Lestrade AC, Wang C, Ditmire T, Hegelich BM.

Phys Rev Lett. 2014 Oct 31;113(18):184801. Epub 2014 Oct 27.

PMID:
25396373
44.

Long-term outcomes following microwave ablation for liver malignancies.

Leung U, Kuk D, D'Angelica MI, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, Fong Y.

Br J Surg. 2015 Jan;102(1):85-91. doi: 10.1002/bjs.9649. Epub 2014 Oct 9.

45.

Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity.

Folkert MR, Singer S, Brennan MF, Kuk D, Qin LX, Kobayashi WK, Crago AM, Alektiar KM.

J Clin Oncol. 2014 Oct 10;32(29):3236-41. doi: 10.1200/JCO.2013.53.9452. Epub 2014 Sep 2.

46.

Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.

Kadota K, Yeh YC, D'Angelo SP, Moreira AL, Kuk D, Sima CS, Riely GJ, Arcila ME, Kris MG, Rusch VW, Adusumilli PS, Travis WD.

Am J Surg Pathol. 2014 Aug;38(8):1118-27. doi: 10.1097/PAS.0000000000000246.

47.

International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.

Melstrom LG, Taylor E, Kuk D, Frankel TL, Panageas K, Haydu L, Sabel MS, Thompson JF, Ariyan C, Coit DG, Brady MS.

Ann Surg Oncol. 2014 Dec;21(13):4324-9. doi: 10.1245/s10434-014-3845-9. Epub 2014 Jun 25.

PMID:
24962937
48.

Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.

Kitano S, Postow MA, Ziegler CG, Kuk D, Panageas KS, Cortez C, Rasalan T, Adamow M, Yuan J, Wong P, Altan-Bonnet G, Wolchok JD, Lesokhin AM.

Cancer Immunol Res. 2014 Aug;2(8):812-21. doi: 10.1158/2326-6066.CIR-14-0013. Epub 2014 May 20.

49.

Observation after a positive sentinel lymph node biopsy in patients with melanoma.

Bamboat ZM, Konstantinidis IT, Kuk D, Ariyan CE, Brady MS, Coit DG.

Ann Surg Oncol. 2014 Sep;21(9):3117-23. doi: 10.1245/s10434-014-3758-7. Epub 2014 May 16.

PMID:
24833100
50.

Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.

Yuan J, Zhou J, Dong Z, Tandon S, Kuk D, Panageas KS, Wong P, Wu X, Naidoo J, Page DB, Wolchok JD, Hodi FS.

Cancer Immunol Res. 2014 Feb;2(2):127-32. doi: 10.1158/2326-6066.CIR-13-0163.

Supplemental Content

Support Center